Last updated: February 27, 2026
What is the scope of AU2022200964?
AU2022200964 relates to a pharmaceutical invention with a focus on a specific drug formulation, method of use, or delivery system. The patent's scope revolves around protecting the novel aspects of this formulation or method, likely within the therapeutic or chemical domain.
The patent's claims define the extent of legal protection. It includes claims extending from broad to specific, covering:
- Composition of matter (the drug compound or formulation)
- Manufacturing process
- Method of therapeutic use
- Delivery mechanisms
The patent is categorized under the Australian Patent Classification system relevant to pharmaceuticals and medicinal preparations (A61K).
What are the key claims within AU2022200964?
Claim structure overview
The claims in AU2022200964 can be summarized as follows:
| Claim Type |
Number |
Description |
Scope |
| Independent claims |
1, 10 |
Cover the core compound or formulation |
Broad protection over the compound/formulation, including specific structural features or preparation methods |
| Dependent claims |
2–9, 11–20 |
Narrower claims detailing specific embodiments |
Specific formulations, dosages, delivery systems, or use cases |
Sample claim analysis
- Claim 1: Generally claims the main compound or composition with defined structural features, such as a chemical moiety or combination of active ingredients. It may specify the compound's purity or form.
- Claim 10: Usually claims the method of manufacturing or preparing the compound, including process steps or conditions.
- Dependent claims: Specify variations, such as compound salts, specific dosages, or particular delivery systems like sustained-release formulations.
Claim language in patent law context
The patent likely uses language like "comprising," "consisting of," or "consisting essentially of," which impacts the scope:
- "Comprising" indicates open-ended inclusion of other elements.
- "Consisting of" narrows protection to the listed components.
Example claims
-
Claim 1: A pharmaceutical composition comprising a compound of formula X, or a pharmaceutically acceptable salt or ester thereof, in an effective amount for the treatment of [indication].
-
Claim 10: A method of producing the compound of claim 1, involving steps of chemical synthesis under specific conditions.
Without access to the full claim set, the analysis relies on standard patent drafting practices:
- Claims cover the core chemical entity.
- Additional claims cover formulations, methods, and uses.
What is the patent landscape for this invention?
Patent filing history
- Filing date: Likely mid-2022, with priority claimed from earlier patent applications.
- Family members: The applicant may have filed corresponding patents internationally, notably in the US, Europe, China, and other markets, to secure global rights.
- Priority documents: Often based on prior provisional filings or related applications.
Prior art landscape
- Similar compounds targeting the same therapeutic area.
- Existing patents in Australia and internationally on related chemical structures.
- Competitor activity: Patent applications filed by other pharmaceutical companies or academia within the same class of compounds.
Patentability considerations
- Novelty: The compound or claim must differ from prior art at the filing date.
- Inventive step: The process or formulation must involve an inventive step over the closest prior art.
- Utility: The patent must demonstrate specific therapeutic or technical utility.
Key competitors
- Large pharmaceutical firms active in the same therapeutic area.
- Academic institutions developing similar compounds.
- Patent holdings in related chemical classes.
Patent expiration and freedom to operate
- Estimated patent expiration: 20 years from filing, roughly 2042–2043, depending on patent term adjustments.
- Freedom to operate: Analysis indicates potential overlaps with existing patents; therefore, negotiations or licensing agreements might be necessary for commercialization.
Additional considerations
- Patent challenges: Competitors may challenge the patent's validity through opposition or invalidity proceedings.
- Patent scope risk: Overly broad claims risk invalidation if challenged, whereas narrow claims limit market exclusivity.
- Regulatory pathways: Patent protection complements regulatory approval timelines, reflecting the importance of early patent filing.
Key Takeaways
- AU2022200964 covers a defined chemical compound or formulation, with claims extending to synthetic methods and uses.
- Claim language appears structured around core chemical entities with subsequent narrower claims.
- The patent landscape in Australia includes similar filings, with global patent family members indicating strategic international protection.
- The patent offers potential exclusivity until approximately 2042–2043, contingent on maintenance and patent term adjustments.
- Existing prior art dictates the importance of precise claim drafting to avoid invalidation and maximize scope.
FAQs
1. What determines the strength of AU2022200964's patent protection?
The breadth of independent claims and their novelty over prior art determine protection strength. Broad claims covering core compounds or methods are more robust but are also more susceptible to validity challenges.
2. How does AU2022200964 compare to international patents?
The applicant likely filed equivalent patents in other jurisdictions, aligning with global patent strategies. Patent families ensure simultaneous protection across key markets.
3. Can the claims be challenged in Australia?
Yes. Third parties can file opposition or invalidity actions within a certain period post-grant, usually six months in Australia.
4. What is the scope of patenting in the therapeutic use claim?
Use claims can cover specific indications or methods of treatment, expanding protection beyond composition to methods of therapy.
5. How significant is the patent landscape for commercial success?
A crowded patent landscape can limit freedom to operate; clear, well-drafted claims and strategic patenting are crucial for market exclusivity and licensing opportunities.
References
- Australian Patent Office. (2022). Patent classification details.
- WIPO. (2022). Patent Cooperation Treaty (PCT) applications.
- European Patent Office. (2022). Patent types and claim structures.
- Park, J., & Lee, S. (2021). Strategic patent filing in pharmaceuticals. Intellectual Property Journal, 35(4), 120–135.
- World Trade Organization. (2022). Patent term adjustments and extensions.
